SIGA Technologies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting a net loss of $2,893,064 for the third quarter and total revenues of $1,316,965.

Key Highlights

  • Q3 2026 total revenues: $1,316,965, down from $2,620,000 in Q3 2025, according to the filing.
  • Q3 2026 net loss: $2,893,064, or $(0.04) per basic and diluted share, compared to a net loss of $6,365,819 in Q3 2025.
  • Nine-month net income: $6,116,118, or $0.09 per basic share, for the nine months ended September 30, 2026, versus $28,709,061 for the same period in 2025.
  • Cash and cash equivalents: $116,380,386 at September 30, 2026, down from $154,966,414 at December 31, 2025.
  • Dividend payment: $43,315,649 paid during the nine months ended September 30, 2026, reflected in cash used in financing activities.
  • Shares outstanding: 71,855,015 shares of common stock as of October 26, 2026, per the filing.
  • Deferred IV TPOXX revenue: Reduced to zero at September 30, 2026, from $10,240,000 at December 31, 2025.

SIGA Technologies Reports Sharply Lower Q3 2026 Revenue and Nine-Month Comparison

SIGA Technologies, Inc. (NASDAQ:SIGA), a Delaware-incorporated biopharmaceutical company headquartered in New York, NY, disclosed in its quarterly report that total revenues for the three months ended September 30, 2026, were $1,316,965, consisting of $233,689 in product sales and supportive services and $1,083,276 in research and development revenues. This compares with total revenues of $2,620,000 for the three months ended September 30, 2025, the filing stated. For the nine-month period ended September 30, 2026, the company reported total revenues of $48,561,798, down from $90,780,818 for the same period in 2025.

The filing disclosed that total operating expenses for Q3 2026 were $7,837,013, resulting in an operating loss of $6,520,048 for the quarter. For the nine months ended September 30, 2026, operating income was $2,064,367, compared to $33,201,891 in the prior-year nine-month period. The company reported a net loss of $2,893,064 for Q3 2026 and net income of $6,116,118 for the nine months ended September 30, 2026, according to the condensed consolidated statements of operations.

The balance sheet as of September 30, 2026, reflected total assets of $172,648,103 and total liabilities of $9,394,256, leaving total stockholders' equity of $163,253,847. The accumulated deficit stood at $80,862,568 at September 30, 2026, compared to $43,070,803 at December 31, 2025. Net cash provided by operating activities for the nine months ended September 30, 2026, was $5,328,262, versus $60,332,261 for the same period in 2025. The filing noted that cash used in financing activities included a dividend payment of $43,315,649 and payment of employee tax obligations for common stock tendered of $598,641.

What Was Disclosed

SIGA Technologies filed its Q3 2026 Form 10-Q covering the period ended September 30, 2026. The filing disclosed quarterly and nine-month revenues, operating results, net income and loss figures, balance sheet data, cash flows, and share count information as of October 26, 2026.